0001209191-11-024585.txt : 20110427
0001209191-11-024585.hdr.sgml : 20110427
20110427160929
ACCESSION NUMBER: 0001209191-11-024585
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20110426
FILED AS OF DATE: 20110427
DATE AS OF CHANGE: 20110427
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6165776000
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kelly Lisa
CENTRAL INDEX KEY: 0001349077
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 11783766
MAIL ADDRESS:
STREET 1: 125 SPRING STREET
CITY: LEXINGTON
STATE: MA
ZIP: 02421
4
1
doc4.xml
FORM 4 SUBMISSION
X0303
4
2011-04-26
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001349077
Kelly Lisa
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST
CAMBRIDGE
MA
02139
0
1
0
0
SVP, Human Resources
Common Stock
2011-04-26
4
M
0
14297
28.84
A
56539
D
Common Stock
2011-04-26
4
S
0
14297
50.50
D
42242
D
Common Stock
1182
I
401(k)
Stock Option
28.84
2011-04-27
4
M
0
14297
0.00
D
2007-10-12
2017-07-11
Common Stock
14297
1907
D
Transaction made pursuant to Ms. Kelly-Croswell's company approved trading plan under Rule 10b5-1.
Right to buy under 2006 Stock and Option Plan, vesting in 16 quarterly installments from 07/12/2007.
Kenneth S. Boger, Attorney-In-Fact
2011-04-27